Opposition and pharmaceutical bodies warn of worsening drug shortages

The launch of these warnings coincides with the deterioration of economic and social indicators in the country, amid rising debates about the financial assumptions of the draft state budget for 2027 and its ability to meet basic needs.
Professionals in the pharmaceutical and health sectors have recorded a sharp decline in the stock of vital medicines, particularly those aimed at treating chronic diseases, cancer, heart disease and diabetes. This acute shortage is due to the Central Pharmacy's unrelenting accumulation of debt for the benefit of manufactured global intelligence, alongside the institution's inability to secure Le Kef's liquidity in hard currency to pay shipment debts on time.
Party leaders and financial experts stressed that the economic policies pursued have led to a slowdown in growth rates and a decline in domestic and foreign investment due to a lack of reform vision. They pointed out that excessive reliance on direct domestic borrowing from the central bank and local banks to finance administrative expenses and the debt service has exacerbated public financing pressures.
Opposition forces and figures and expert reports have issued similar warnings about the deterioration of the country's financial indicators as debate on a draft budget for 2027 begins in Parliament.
Opposition parties have criticized the confinement of the executive to speculation and monopoly, stressing that the commodity shortage is mainly linked to a lack of public finances to pay the debts of the grain board and commercial debts and a decline in the support system. The democratic and legal forces demanded that they stop restricting political and trade union activity, and launch an economic and social dialogue to develop an urgent rescue plan and revive public institutions threatened with bankruptcy.
